Amanote Research

Amanote Research

    RegisterSign In

High-Density Lipoprotein Cholesterol Targeting for Novel Drug Discovery: Where Have We Gone Wrong?

Expert Opinion on Drug Discovery - United Kingdom
doi 10.1517/17460441.2014.871257
Full Text
Open PDF
Abstract

Available in full text

Categories
Drug Discovery
Date

December 12, 2013

Authors
Joan Carles Escolà-GilLídia CedóFrancisco Blanco-Vaca
Publisher

Informa Healthcare


Related search

Serving Customers by Going Where We Have Not Gone Before

Customer Needs and Solutions
2015English

High-Density Lipoprotein Cholesterol in Diabetes.

BMJ
1978English

Where Have the Flagships Gone?

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Non-High Density Lipoprotein Cholesterol Versus Low Density Lipoprotein Cholesterol as a Discriminating Factor for Myocardial Infarction

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2012English

MicroRNAs and High-Density Lipoprotein Cholesterol Metabolism

International Heart Journal
MedicineCardiovascular MedicineCardiology
2015English

High-Density Lipoprotein Cholesterol Determination in AMHTS

Japanese journal of AMHTS
1980English

Serum High Density Lipoprotein Cholesterol in Alcoholics

The Journal of Japan Atherosclerosis Society
1981English

Where Have All the Bilneys Gone?

Medical Journal of Australia
Medicine
2014English

Where Have All the Bishops Gone?

Acta Theologica
Religious Studies
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy